Citius Pharmaceuticals Co-Founder and CEO Discusses Promising Phase 3 Clinical Trial Results for Mino-Lok, a Treatment Aimed at Catheter Salvage in Patients with Central Linear Catheter-Associated Infections

In an interview with Pharm Exec Editor-in-Chief Don Tracy, Leonard Mazur, co-founder and CEO of Citius Pharmaceuticals, discusses the latest top-line results from a pivotal Phase 3 clinical trial of Mino-Lok, a potential cure for catheter infections.